When the Bone Marrow Breaks Down: Primary Myelofibrosis
From The Intern At Work: Internal Medicine by Medicine Pods: The Intern at Work
January 25, 2026 · 23 min
About this episode
This episode discusses an approach to myelofibrosis and reviews new treatment agents approved in Canada in 2025.
Send us Fan Mail In this episode, we discuss an approach to myelofibrosis, including a review of new treatment agents that just received approval in Canada in 2025! Written by: Dr. Ayesha Warsi. Reviewed by: Drs. Zachary Leiderman, Clarissa Skorupski, and Ryan Luther. Support the show
Topics covered
- myelofibrosis
- treatment agents
- bone marrow
- internal medicine
- healthcare advancements
Keywords
- myelofibrosis
- bone marrow
- treatment
- health
- medicine
- Canada
- internal medicine
Mentioned in this episode
Organizations: Canada
More episodes of The Intern At Work: Internal Medicine
- Sickle Cell Disease and its Acute Complications · May 31, 2026 · 20 min
- Lungs, Drugs, and Nasal Prongs: An Approach to Drug Induced Interstitial Lung Disease · May 17, 2026 · 12 min
- Lungs, Liver, and a Missing Link: Alpha-1-Antitrypsin Deficiency Explained · May 3, 2026 · 13 min
- Peering into the Pipes: Coronary Angiography · April 19, 2026 · 18 min
- Untangling the Web – An approach to Cryptogenic Organizing Pneumonia · April 5, 2026 · 12 min
- Overview of Lung Transplantation · March 22, 2026 · 24 min
Explore listener stats, chart rankings, contacts and more on the The Intern At Work: Internal Medicine podcast page.